English
English
/
中文
Home Page
Home
About Us
Nav
R&D
Nav
News
Nav
Job Opening
Nav
Contact Us
Nav
热爱生活....
Article list
R&D VP and Director
2023-10-12
Neoletix entered into an exclusive license agreement with Sichuan Yuanda Shuyang for the development
2022-11-15
IND Application of NX01 was Approved
2022-09-20
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of rFⅧ
2021-07-02
Partnership to Aid Access to Man-made FVIII for Patients in China
2021-06-11
Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII
2021-02-20
里程碑达成 | 金斯瑞蓬勃生物助力555000a会员中心生物生产的200L GMP凝血因子VIII完成交付
2021-02-09
促凝血药物开发
[ 站内链接 ]
2020-07-10
中国北京研究中心
[ 站内链接 ]
2020-07-09
美国亚特兰大研究中心
[ 站内链接 ]
2020-07-09
罕见病药物开发
[ 站内链接 ]
2020-07-09
广谱抗肿瘤药物开发
[ 站内链接 ]
2020-07-09
抗凝血药物开发
[ 站内链接 ]
2020-07-09
药审论坛 | 重组人凝血因子Ⅷ和Ⅸ临床试验共性问题的探讨
[ 新闻动态 ]
2020-05-05
委托药明生物合作开发ADC项目
[ 站内链接 ]
2020-04-30
Senior Scientist
[ 加入我们 ]
2020-02-20
Principal Scientist
[ 加入我们 ]
2020-02-20
Scientist
[ 加入我们 ]
2020-01-17
555000a会员中心生物与南京金斯瑞达成合作
[ 新闻动态 ]
2019-11-28
555000a会员中心生物与南京金斯瑞达成合作协议
[ 站内链接 ]
2019-11-05
Prev
1
2
Next
13th Kechuang St. Beijing Economic Development Area, Beijing
13520295482
info@neoletix.com
Passionate for life and future
Dedicated to the research and development in the area of hemostasis, thrombosis, rare diseases and cancer therapies.